- The Use of Whole Blood and Low Titer Group O Whole Blood in Managing Emergency and Trauma Patients
-
Lim HJ, Cho D, Park CY, Kim TY
- KMID: 2555555
- Korean J Blood Transfus.
- 2024 Apr;35(1):14-26.
- doi: 10.17945/kjbt.2024.35.1.1 4
Since the mid-2000s, massive blood transfusion protocols and damage control resuscitation have improved the prognosis of trauma patients. As a part of damage control resuscitation, whole blood transfusion, especially using... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Appropriateness of Platelet Transfusions at Two Tertiary Hospitals
-
Oh YB, Lim HJ, Kwon YJ, Choi YJ, Park JH, Choi HJ, Choi HW, Kee SJ, Nah EH, Shin MG, Shin JH
- KMID: 2555557
- Korean J Blood Transfus.
- 2024 Apr;35(1):33-43.
- doi: 10.17945/kjbt.2024.35.1.3 3
Background: Appropriate platelet transfusion is essential for patient blood management and allocating limited healthcare resources. Therefore, this study evaluated the appropriateness of platelet transfusion in two tertiary hospitals. Methods: At Chonnam... -
- CITED
-
- Close
- SHARE
-
- Close
- Global Use of Cryopreserved Platelets
-
Lim YA, Youn KW, Park SJ
- KMID: 2555554
- Korean J Blood Transfus.
- 2024 Apr;35(1):1-13.
- doi: 10.17945/kjbt.2024.35.1.1
The Valeri method, introduced in 1972 with dimethyl sulfoxide (DMSO) as a cryoprotective agent, has evolved into a no-wash technique widely employed for cryopreservation of platelets. Cryopreserved platelets (CP) are... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Indications for RHD Genotyping in Koreans
-
Lee JH, Seo J, Park MY, Lee JK, Cho D
- KMID: 2555556
- Korean J Blood Transfus.
- 2024 Apr;35(1):27-32.
- doi: 10.17945/kjbt.2024.35.1.2 7
RHD genotyping is used primarily when serological tests alone are insufficient to accurately determine the RhD blood type, especially in RhD-negative or RhD variant (D variant) cases. The frequency of... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 Convalescent Plasma Therapy in Korea
-
Roh J, Kim YG, Kim JN, Kim S
- KMID: 2555558
- Korean J Blood Transfus.
- 2024 Apr;35(1):44-47.
- doi: 10.17945/kjbt.2024.35.1.4 4
A global effort was made to respond to COVID-19 using convalescent plasma therapy. The United States Food and Drug Administration Emergency Use Authorization facilitated rapid deployment, enabling the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
